Delivery Order SPE2DR25D2006-SPE2DR26F56SV
- Not listed
- The Defense Logistics Agency awarded a $27,358.58 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, executed on December 5, 2025, represents a firm fixed price delivery order with a completion date of December 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,999.53 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract specifies a place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters, with an ultimate completion date of December 15, 2025. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $11,460.84 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) with a completion date of December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,178.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 8, 2025, with completion scheduled for December 9, 2025. This contract is unset-aside and represents a competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) with a contract value of $2,164.46. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, under a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,511.11 on November 3, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,186.32 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 count) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical supply will be delivered to the...
- The Defense Logistics Agency awarded a $12,625.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packages) on November 13, 2025, with completion targeted for November 14, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ondansetron HCl 4 mg tablets in quantities of 30, with a ceiling value of $23,438.54. This is a firm fixed price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $15,178.69. This is a firm fixed-price, non-set-aside delivery order awarded on May 5, 2025, with an ultimate completion date of May 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56SVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,315.30 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packages). This competitive award, issued on December 12, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare operations globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-established as a critical federal vendor for the Defense Logistics Agency's medical supply chain. The company's extensive contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains for military and veteran healthcare systems. This delivery order for Ondansetron, a standard antiemetic medication commonly used in military medical settings, exemplifies the routine pharmaceutical commodity deliveries that AmerisourceBergen executes under its primary IDC with DLA, which encompasses brand-name and generic drugs, vaccines, and specialized medical supplies supporting defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/11/25 |